XML 124 R95.htm IDEA: XBRL DOCUMENT
v3.23.4

Commitments and Contingencies - License Agreement (Details) - USD ($) |  |  |  |  |  | 1 Months Ended | 9 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Sep. 28, 2022 | May 22, 2022 | Apr. 15, 2022 | Nov. 15, 2021 | Feb. 15, 2021 | Jul. 31, 2022 | Jul. 31, 2021 | Nov. 30, 2020 | Oct. 31, 2020 | Nov. 30, 2018 | Sep. 30, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Commitments and Contingencies |  |  |  |  |  |  |  |  |  |  |  |  |
One-time non-refundable fee of license agreement |  |  |  |  |  |  |  |  |  | $ 50,000 |  |  |
Reimbursement of licensor's patent costs at execution of the license |  |  |  |  |  |  |  |  |  | 145,000 |  |  |
Minimum annual license fee |  |  |  |  |  |  |  |  |  | $ 25,000 |  |  |
Period within each anniversary of the effective date of the license that minimum annual license fee must be paid |  |  |  |  |  |  |  |  |  | 60 days |  |  |
Maximum total milestone payments |  |  |  |  |  |  |  |  |  |  | $ 1,550,000 | $ 1,550,000 |
Period within which the milestone payments should be paid upon achievement of the milestone |  |  |  |  |  |  |  |  |  |  | 60 days | 60 days |
Enrollment of first patient in a phase II clinical trial of a therapeutic product or process |  |  |  |  |  |  |  |  |  |  | $ 100,000 | $ 100,000 |
Enrollment of first patient in a phase III clinical trial of a therapeutic product or process |  |  |  |  |  |  |  |  |  |  | 200,000 | 200,000 |
First commercial sale of a therapeutic product or process |  |  |  |  |  |  |  |  |  |  | 1,000,000 | 1,000,000 |
Filing of an application for regulatory approval of a clinical diagnostic product or process |  |  |  |  |  |  |  |  |  |  | 100,000 | 100,000 |
First regulatory approval of a clinical diagnostic product or process |  |  |  |  |  |  |  |  |  |  | $ 150,000 | $ 150,000 |
Royalties calculated as a percentage to on net sales of licensed products for therapeutic products or processes |  |  |  |  |  |  |  |  |  |  | 3.00% | 3.00% |
Royalties calculated as a percentage to on net sales of licensed products for clinical diagnostic products and processes |  |  |  |  |  |  |  |  |  |  | 6.00% | 6.00% |
Royalties calculated as a percentage of any and all sublicense income |  |  |  |  |  |  |  |  |  |  | 30.00% | 30.00% |
Notice period for terminating License |  |  |  |  |  |  |  |  |  |  | 90 days | 90 days |
Period after the first commercial sale that the License shall continue if not terminated by the company |  |  |  |  |  |  |  |  |  |  | 10 years | 10 years |
Royalty percentage beyond the term of the License |  |  |  |  |  |  |  |  |  |  | 1.50% | 1.50% |
Minimum annual license fee for Patent Family 1 |  |  |  |  |  |  |  | $ 30,000 | $ 25,000 |  |  |  |
Minimum annual license fee related to Patent Family 2 |  |  |  |  |  |  |  |  |  |  | $ 10,000 | $ 10,000 |
Cost of option agreement |  |  | $ 7,500 |  | $ 5,000 |  |  |  |  |  |  |  |
Terms of extended option agreement with licensor |  |  | 6 months |  | 6 months |  |  |  |  |  |  |  |
Cost of extended option agreement | $ 10,000 | $ 5,000 | $ 5,000 | $ 0 | $ 5,000 |  |  |  |  |  |  |  |
Accrued license obligations |  |  |  |  |  |  |  |  |  |  | $ 61,322 | $ 57,820 | $ 20,487
Computer-based phishing attack involving, amount |  |  |  |  |  |  | $ 526,435 |  |  |  |  |  |
Computer-based phishing attack involving recovery, amount |  |  |  |  |  | $ 45,682 |  |  |  |  |  |  |
Computer-based phishing attack involving recovery period |  |  |  |  |  | 5 days |  |  |  |  |  |  |
Computer based phishing attack, held by receiving bank pending resolution. |  |  |  |  |  | $ 480,753 |  |  |  |  |  |  |
Terms of option agreement with Licensor |  |  |  |  | 6 months |  |  |  |  |  |  |  |

X
- Definition It represents the amount of accrued license obligations. + References No definition available. + Details
Name: | rnaz_AccruedLicenseObligations
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of computer based phishing attack, held by receiving bank pending resolution. + References No definition available. + Details
Name: | rnaz_ComputerBasedPhishingAttackHeldByReceivingBankPendingResolution
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of computer based phishing attack involving. + References No definition available. + Details
Name: | rnaz_ComputerBasedPhishingAttackInvolving
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of computer based phishing attack involving recovery. + References No definition available. + Details
Name: | rnaz_ComputerBasedPhishingAttackInvolvingRecovery
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Computer based phishing attack involving recovery period. + References No definition available. + Details
Name: | rnaz_ComputerBasedPhishingAttackInvolvingRecoveryPeriod
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the cost of extended option agreement. + References No definition available. + Details
Name: | rnaz_CostOfExtendedOptionAgreement
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cost of option agreement. + References No definition available. + Details
Name: | rnaz_CostOfOptionAgreement
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition It represents the maximum total milestone payments. + References No definition available. + Details
Name: | rnaz_MaximumTotalMilestonePayments
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition It represents the milestone payment due when enrollment of first patient in a phase II clinical trial of a therapeutic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenEnrollmentOfFirstPatientInPhaseIiClinicalTrialOfTherapeuticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition It represents the milestone payment due when enrollment of first patient in a phase III clinical trial of a therapeutic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenEnrollmentOfFirstPatientInPhaseIiiClinicalTrialOfTherapeuticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition It represents the milestone payment due when filing of an application for regulatory approval of a clinical diagnostic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenFilingOfApplicationForRegulatoryApprovalOfClinicalDiagnosticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition It represents the milestone payment due when first commercial sale of a therapeutic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenFirstCommercialSaleOfTherapeuticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition It represents the milestone payment due when first regulatory approval of a clinical diagnostic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenFirstRegulatoryApprovalOfClinicalDiagnosticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition It represents the minimum annual license fee. + References No definition available. + Details
Name: | rnaz_MinimumAnnualLicenseFee
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum annual license fee for Patent Family 1. + References No definition available. + Details
Name: | rnaz_MinimumAnnualLicenseFeeForPatentFamily1
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum annual license fee related to Patent Family 2. + References No definition available. + Details
Name: | rnaz_MinimumAnnualLicenseFeeRelatedToPatentFamily2
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition It represents the notice period for terminating License. + References No definition available. + Details
Name: | rnaz_NoticePeriodForTerminatingLicense
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the one-time non-refundable fee for license of license agreement. + References No definition available. + Details
Name: | rnaz_OneTimeNonRefundableFeeOfLicenseAgreement
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition It represents the period after the first commercial sale that the License shall continue if not terminated by the company. + References No definition available. + Details
Name: | rnaz_PeriodAfterFirstCommercialSaleThatLicenseShallContinueIfNotTerminatedByCompany
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the Period within each anniversary of the effective date of the License that minimum annual license fee must be paid. + References No definition available. + Details
Name: | rnaz_PeriodWithinEachAnniversaryOfEffectiveDateOfLicenseThatMinimumAnnualLicenseFeeMustBePaid
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the period within which the milestone payments should be paid upon achievement of the milestone. + References No definition available. + Details
Name: | rnaz_PeriodWithinWhichMilestonePaymentsShouldBePaidUponAchievementOfMilestone
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the reimbursement of Licensor's patent costs at execution of the License. + References No definition available. + Details
Name: | rnaz_ReimbursementOfLicensorsPatentCostsAtExecutionOfLicense
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalties calculated as a percentage of any and all sublicense income. + References No definition available. + Details
Name: | rnaz_RoyaltiesCalculatedAsPercentageOfAnyAndAllSublicenseIncome
Namespace Prefix: | rnaz_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the royalties calculated as a percentage to on net sales of licensed products for clinical diagnostic products and processes. + References No definition available. + Details
Name: | rnaz_RoyaltiesCalculatedAsPercentageToOnNetSalesOfLicensedProductsForClinicalDiagnosticProductsAndProcesses
Namespace Prefix: | rnaz_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the royalties calculated as a percentage to on net sales of licensed products for therapeutic products or processes. + References No definition available. + Details
Name: | rnaz_RoyaltiesCalculatedAsPercentageToOnNetSalesOfLicensedProductsForTherapeuticProductsOrProcesses
Namespace Prefix: | rnaz_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty percentage beyond the term of the License. + References No definition available. + Details
Name: | rnaz_RoyaltyPercentageBeyondTermOfLicense
Namespace Prefix: | rnaz_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the terms of extended option agreement with Licensor. + References No definition available. + Details
Name: | rnaz_TermsOfExtendedOptionAgreementWithLicensor
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Terms of option agreement with Licensor. + References No definition available. + Details
Name: | rnaz_TermsOfOptionAgreementWithLicensor
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration